indirubin-3'-monoxime has been researched along with Left Ventricular Hypertrophy in 1 studies
indirubin-3'-monoxime: has antiangiogenic activity
indirubin-3'-monoxime : A member of the class of biindoles that is indirubin in which the keto group at position 3' has undergone condensation with hydroxylamine to form the corresponding oxime.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barillas, R | 1 |
| Friehs, I | 1 |
| Cao-Danh, H | 1 |
| Martinez, JF | 1 |
| del Nido, PJ | 1 |
1 other study available for indirubin-3'-monoxime and Left Ventricular Hypertrophy
| Article | Year |
|---|---|
Inhibition of glycogen synthase kinase-3beta improves tolerance to ischemia in hypertrophied hearts.
Topics: Animals; Body Weight; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Glycolysis; Hyper | 2007 |